Last reviewed · How we verify

Stimus (NNG-DEPO)

Nanogen Pharmaceutical Biotechnology Joint Stock Company · Phase 3 active Biologic

Stimus (NNG-DEPO) is a Central nervous system stimulant Biologic drug developed by Nanogen Pharmaceutical Biotechnology Joint Stock Company. It is currently in Phase 3 development for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.

Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.

Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.

At a glance

Generic nameStimus (NNG-DEPO)
SponsorNanogen Pharmaceutical Biotechnology Joint Stock Company
Drug classCentral nervous system stimulant
ModalityBiologic
Therapeutic areaNeurology
PhasePhase 3

Mechanism of action

Stimus (NNG-DEPO) is a central nervous system stimulant that increases the levels of dopamine and norepinephrine in the brain, which can help improve focus, attention, and impulse control. It is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Stimus (NNG-DEPO)

What is Stimus (NNG-DEPO)?

Stimus (NNG-DEPO) is a Central nervous system stimulant drug developed by Nanogen Pharmaceutical Biotechnology Joint Stock Company, indicated for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.

How does Stimus (NNG-DEPO) work?

Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.

What is Stimus (NNG-DEPO) used for?

Stimus (NNG-DEPO) is indicated for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.

Who makes Stimus (NNG-DEPO)?

Stimus (NNG-DEPO) is developed by Nanogen Pharmaceutical Biotechnology Joint Stock Company (see full Nanogen Pharmaceutical Biotechnology Joint Stock Company pipeline at /company/nanogen-pharmaceutical-biotechnology-joint-stock-company).

What drug class is Stimus (NNG-DEPO) in?

Stimus (NNG-DEPO) belongs to the Central nervous system stimulant class. See all Central nervous system stimulant drugs at /class/central-nervous-system-stimulant.

What development phase is Stimus (NNG-DEPO) in?

Stimus (NNG-DEPO) is in Phase 3.

What are the side effects of Stimus (NNG-DEPO)?

Common side effects of Stimus (NNG-DEPO) include Insomnia, Headache, Anxiety, Nervousness, Dizziness.

Related